KMT2A | Lysine (K)-specific methyltransferase 2A | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
KMT2B | Lysine (K)-specific methyltransferase 2B | Cancer-related genes Enzymes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
L3MBTL1 | L(3)mbt-like 1 (Drosophila) | Predicted intracellular proteins Transcription factors
| | | | | Mixed |
LYAR | Ly1 antibody reactive | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
MAZ | MYC-associated zinc finger protein (purine-binding transcription factor) | Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MBD1 | Methyl-CpG binding domain protein 1 | Cancer-related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MECOM | MDS1 and EVI1 complex locus | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |
MTA1 | Metastasis associated 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins Transcription factors
| | | | | Expressed in all |
MTA2 | Metastasis associated 1 family, member 2 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MTA3 | Metastasis associated 1 family, member 3 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MTF1 | Metal-regulatory transcription factor 1 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MYNN | Myoneurin | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
MYT1 | Myelin transcription factor 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
MYT1L | Myelin transcription factor 1-like | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
MZF1 | Myeloid zinc finger 1 | Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR0B1 | Nuclear receptor subfamily 0, group B, member 1 | Cancer-related genes Disease related genes Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NR0B2 | Nuclear receptor subfamily 0, group B, member 2 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1D1 | Nuclear receptor subfamily 1, group D, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1D2 | Nuclear receptor subfamily 1, group D, member 2 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H2 | Nuclear receptor subfamily 1, group H, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H3 | Nuclear receptor subfamily 1, group H, member 3 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR1H4 | Nuclear receptor subfamily 1, group H, member 4 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1I2 | Nuclear receptor subfamily 1, group I, member 2 | FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR1I3 | Nuclear receptor subfamily 1, group I, member 3 | Cytoskeleton related proteins Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR2C1 | Nuclear receptor subfamily 2, group C, member 1 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2C2 | Nuclear receptor subfamily 2, group C, member 2 | Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR2E1 | Nuclear receptor subfamily 2, group E, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
NR2E3 | Nuclear receptor subfamily 2, group E, member 3 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Not detected |
NR2F1 | Nuclear receptor subfamily 2, group F, member 1 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NR2F2 | Nuclear receptor subfamily 2, group F, member 2 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR2F6 | Nuclear receptor subfamily 2, group F, member 6 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR3C1 | Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) | Disease related genes FDA approved drug targets Nuclear receptors Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR3C2 | Nuclear receptor subfamily 3, group C, member 2 | Disease related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A1 | Nuclear receptor subfamily 4, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
NR4A2 | Nuclear receptor subfamily 4, group A, member 2 | Cancer-related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR4A3 | Nuclear receptor subfamily 4, group A, member 3 | Cancer-related genes Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
NR5A1 | Nuclear receptor subfamily 5, group A, member 1 | Disease related genes Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
NR5A2 | Nuclear receptor subfamily 5, group A, member 2 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Mixed |
NR6A1 | Nuclear receptor subfamily 6, group A, member 1 | Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
OSR1 | Odd-skipped related transciption factor 1 | Predicted intracellular proteins Transcription factors
| | | | | Mixed |
OSR2 | Odd-skipped related transciption factor 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OVOL1 | Ovo-like zinc finger 1 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OVOL2 | Ovo-like zinc finger 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
OVOL3 | Ovo-like zinc finger 3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
PATZ1 | POZ (BTB) and AT hook containing zinc finger 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PEG3 | Paternally expressed 3 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
PGR | Progesterone receptor | Cancer-related genes FDA approved drug targets Nuclear receptors Predicted intracellular proteins Transcription factors
| | | | | Group enriched |
PLAG1 | Pleiomorphic adenoma gene 1 | Cancer-related genes Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Mixed |
PLAGL1 | Pleiomorphic adenoma gene-like 1 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
PLAGL2 | Pleiomorphic adenoma gene-like 2 | Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |